Advertisement
Screener

Design Therapeutics, Inc. (DSGN) Other

Design Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2021-11-09: Form 10-Q; Item Smaller reporting company; As filed No.
  • 2021-08-09: Form 10-Q; Item Smaller reporting company; As filed No.
  • 2021-05-10: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · DSGN · NASDAQ.
  • 2021-05-10: Form 10-Q; Item Smaller reporting company; As filed No.
FiledFormItemAs filed
2021-11-0910-QSmaller reporting companyNo
2021-08-0910-QSmaller reporting companyNo
2021-05-1010-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · DSGN · NASDAQ
2021-05-1010-QSmaller reporting companyNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
GERON CORP (GERN)United States$0.803B-12.14
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53